In a patient with systemic lupus erythematosus presenting with a blood pressure of 148/94 mmHg and a temperature of 37.8 °C, what is the appropriate initial management?

Initial Management of SLE Patient with BP 148/94 and Temperature 37.8°C

This patient requires immediate assessment for infection versus lupus flare, with concurrent initiation of blood pressure control and evaluation for renal involvement.

Immediate Diagnostic Priorities

The presentation demands urgent differentiation between two critical scenarios:

1. Rule Out Infection First

The low-grade fever (37.8°C) with hypertension requires immediate infection workup, as patients with SLE rarely have elevated CRP levels, and significant CRP elevation (especially >50 mg/L) with clinical suspicion mandates exclusion of superimposed infection 1. This is particularly critical given that severe leucopenia and lymphopenia in SLE are associated with infection occurrence 1.

Obtain immediately:

• Complete blood count with differential (assess for leucopenia/lymphopenia)
• CRP level (if markedly elevated, strongly suggests infection)
• Blood and urine cultures if infection suspected
• Urinalysis with microscopy

2. Assess for Lupus Nephritis and Disease Flare

The hypertension (148/94 mmHg) is concerning for renal involvement, as serum creatinine, urine sediment analysis, proteinuria, and blood pressure have predictive value for the presence and outcome of kidney involvement 1. Hypertension is a key variable associated with renal survival at 5 years 1.

Obtain concurrently:

• Serum creatinine and albumin
• Urinalysis with microscopy (looking for active sediment: RBCs, WBCs, casts)
• Urine protein-to-creatinine ratio
• Complement levels (C3, C4)
• Anti-dsDNA antibodies
• Complete metabolic panel

Blood Pressure Management

Initiate antihypertensive therapy immediately at this BP level (148/94 mmHg) 2. The target depends on renal status:

• Without lupus nephritis: Target <140/90 mmHg initially
• With lupus nephritis or proteinuria: Target <130/80 mmHg 2
• All hypertensive lupus patients should be considered high cardiovascular risk, with optimal BP <130/80 mmHg 2

First-line agent: ACE inhibitor or ARB 2. These are safe and efficacious in lupus patients and provide renoprotection if nephritis is present 3.

Temperature Management Strategy

If Infection Suspected (CRP >50 mg/L, clinical signs):

• Hold or reduce immunosuppression temporarily
• Initiate empiric antibiotics after cultures
• Consider Pneumocystis jirovecii prophylaxis status 3

If Lupus Flare More Likely (normal/low CRP, active sediment, low complements):

• This may represent active lupus requiring immunosuppression adjustment
• The fever could be lupus-related rather than infectious

Concurrent General Management

All SLE patients should receive:

• Hydroxychloroquine 5 mg/kg/day (real body weight) unless contraindicated 3, 4, 5
• Cardiovascular risk assessment and management 3, 1
• Blood pressure optimization with RAAS blockade 3

Critical Decision Point at 24-48 Hours

Based on initial workup results:

Scenario A: Infection Confirmed

• Treat infection aggressively
• Temporarily hold/reduce immunosuppression
• Control BP with ACE-I/ARB
• Resume lupus therapy after infection controlled

Scenario B: Active Lupus Nephritis (proteinuria, active sediment, low complements)

• If Class III/IV nephritis confirmed: Initiate induction therapy with mycophenolate mofetil 2-3 g/day OR low-dose cyclophosphamide, plus glucocorticoids (methylprednisolone 500-2500 mg IV, then prednisone 0.3-0.5 mg/kg/day) 6, 3
• Consider add-on belimumab or voclosporin for enhanced response 6, 3, 4
• Aggressive BP control to <130/80 mmHg 2

Scenario C: Extrarenal Flare Without Infection

• Optimize hydroxychloroquine
• Consider immunosuppressive agents (methotrexate, azathioprine, mycophenolate) or biologics (belimumab, anifrolumab) 4, 5
• Minimize glucocorticoids (bridge only, taper to ≤5 mg/day) 4

Common Pitfalls to Avoid

1. Do not assume fever is always lupus-related - infection must be excluded first, especially with immunosuppression 1
2. Do not delay BP treatment - hypertension predicts worse renal outcomes 1
3. Do not overlook renal involvement - up to 45% of lupus nephritis patients experience relapses 1
4. Do not use high-dose long-term glucocorticoids - minimize to ≤5 mg/day prednisone equivalent 6, 4

The key is simultaneous evaluation for both infection and lupus activity while immediately addressing the hypertension, as delay in any of these domains increases morbidity and mortality risk.